(ANTIMEDIA) — The case for employing 3,4-methylenedioxymethamphetamine, or MDMA, to treat post-traumatic stress disorder (PTSD) grew stronger this week. A study published in the Lancet Journal of Psychiatry documented promising results when used in conjunction with psychotherapy, adding to previous similar findings. A small study of 26 veterans and first responders suffering from PTSD conducted at the Medical University of […]
Source